Arbutus Biopharma
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $1,726 | $1,532 | $2,145 | $4,658 |
Gross Profit | 1,370 | 1,177 | 1,786 | 4,289 |
EBITDA | -21,016 | -18,828 | -20,161 | -21,558 |
EBIT | -21,372 | -19,183 | -20,520 | -21,927 |
Net Income | -19,796 | -17,875 | -19,312 | -20,104 |
Net Change In Cash | 1,726 | 1,532 | 2,145 | 4,658 |
Free Cash Flow | -14,265 | -19,390 | -16,212 | -21,816 |
Cash | 62,788 | 43,101 | 26,285 | 17,531 |
Basic Shares | 188,041 | 175,625 | 168,435 | 167,512 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $18,141 | $39,019 | $10,988 | $6,914 |
Gross Profit | 16,737 | 37,592 | 9,235 | -40,567 |
EBITDA | -76,630 | -61,031 | -71,523 | -57,095 |
EBIT | -78,034 | -62,458 | -73,276 | -59,073 |
Net Income | -72,849 | -69,456 | -77,351 | -65,211 |
Net Change In Cash | 18,141 | 39,019 | 10,988 | 6,914 |
Cost of Revenue | -78,484 | 57,026 | 20,396 | |
Free Cash Flow | -86,944 | -35,868 | -68,341 | -51,670 |
Cash | 26,285 | 30,776 | 109,282 | 52,251 |
Basic Shares | 165,960 | 150,939 | 106,242 | 75,835 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.11 |
2024-03-31 | -$0.10 |
2023-12-31 | -$0.12 |
2023-09-30 | -$0.12 |
